Effect of Topical Lidocaine on Warm and Cold Sensation in Healthy Individuals

NCT ID: NCT04865185

Last Updated: 2021-04-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-01

Study Completion Date

2022-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the present study is to systematically test the occurrence of paradoxical and illusory responses to cold and warm stimuli in healthy volunteers with artificial sensory loss.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Efficient thermal sensation is important for adequate behavioral response to cold or warm stimuli and early signs of neuropathy can be changes in the thermal sensation.

Alterations in thermal perception can results in paradoxical heat sensation (a warm perception when the skin is cooled) or a peculiar/burning sensation when the skin is stiumlated with simultaneous warm and cold (a "thermal grill").

Clarifying the occurrence of these paradoxical and illusory sensations, may help understanding early signs of peripheral neuropathy as well as thermal sensory perception.

The investigators plan to conduct a study on thermal sensory perception using a model of sensory loss in healthy volunteers and systematically test the occurrence of paradoxical heat sensations and responses to the thermal grill.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neuropathy;Peripheral Thermal Hypesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Xylocaine spray 100mg/ml

Topical application

Group Type ACTIVE_COMPARATOR

Xylocaine spray 100mg/ml

Intervention Type DIAGNOSTIC_TEST

Topical application

Ethanol

Topical application

Group Type PLACEBO_COMPARATOR

Ethanol

Intervention Type DIAGNOSTIC_TEST

Topical application

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Xylocaine spray 100mg/ml

Topical application

Intervention Type DIAGNOSTIC_TEST

Ethanol

Topical application

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy subjects
* Age between 18 and 40 years
* Participant is able and willing to give informed consent.

Exclusion Criteria

* Unable to understand and speak Danish
* Non-cooperative
* Chronic pain or acute pain the past week lasting more than 4 hours or pain on the day of investigation
* Pain medication within the last week
* Medication within the last week that can affect assessment
* Psychiatric or neurological disease and diseases that may affect the assessment
* Sensory disturbances
* History or symptoms of significant diseases (e.g. psychiatric or neurological disease, diseases that may affect the assessment, sensory disturbances, cancer, diabetes mellitus, liver diseases, kidney diseases, cardiovascular diseases)
* Pregnancy or lactation
* Jetlag or sleep deprivation
* Alcohol or drug abuse
* Consumption of cannabis the last 4 weeks and consumption of alcohol in the last 48 hours
* Any abnormality of the skin or of vascular origin at application site
* History of hypersensitivity to lidocaine, other amide-type anesthetics, or other contents of the lidocaine or vehicle
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Aarhus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ellen L Schaldemose, MD

Role: PRINCIPAL_INVESTIGATOR

Danish Pain Research Center, Aarhus University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Danish Pain Research Center, Aarhus University, Aarhus University Hospital

Aarhus N, , Denmark

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ellen L Schaldemose, MD

Role: CONTACT

+45 93501942

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ellen L Schaldemose

Role: primary

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TLH21

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pain Perception: Lidocaine Rate/Temp/Buffer
NCT02823002 ACTIVE_NOT_RECRUITING NA
Tenaculum Pain Control Study
NCT01421641 COMPLETED PHASE4